They've already stated where revenue would fall for the quarter; between $1.65m-$1.75m. No real surprises in the 4c, although it's certainly disappointing. They won't say anything until/unless they re-list. Wouldn't surprise me if they get a low-ball offer for the whole thing. The tech itself is probably worth between $US20m-$US30m. It's not as though there isn't a market for it. If they can sputter and stumble as much as AXP has and still have $8m in sales...Imagine plugging the product in to an established sales force at J&J or Stryker etc.
They've already stated where revenue would fall for the quarter;...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable